Theoretical view of REM sleep function: maintenance of catecholamine systems in the central nervous system.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001921:Brain / Q000502:physiology*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000502:physiology*; D002415:Cats; D004569:Electroencephalography; D004597:Electroshock; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008954:Models, Biological; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D010293:Pargyline / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D012892:Sleep Deprivation; D012895:Sleep, REM / Q000187:drug effects*; D013315:Stress, Psychological
D000928:Antidepressive Agents; D002395:Catecholamines; D006892:Hydroxydopamines; D009419:Nerve Tissue Proteins; D012110:Reserpine; D010293:Pargyline; D010830:Physostigmine; D000661:Amphetamine; D012601:Scopolamine; D007099:Imipramine